Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-171458
Filing Date
2018-05-23
Accepted
2018-05-23 08:31:32
Documents
4
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 d587186d10qa.htm 10-Q/A 26033
2 EX-10.1 d587186dex101.htm EX-10.1 17608
3 EX-31.1 d587186dex311.htm EX-31.1 2343
4 EX-31.2 d587186dex312.htm EX-31.2 2375
  Complete submission text file 0001193125-18-171458.txt   49600
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 033-80623 | Film No.: 18854126
SIC: 2835 In Vitro & In Vivo Diagnostic Substances